Viatris Inc (NASDAQ:VTRS)
| 10.91 Delayed Data As of 4:00pm ET |  -0.01 / -0.09%Today’s Change | 8.42 Today|||52-Week Range 15.60 | -19.36% Year-to-Date |
Latest VTRS News | Press Releases
| Viatris (VTRS) Down 1.5% Since Last Earnings Report: Can It Rebound? 11:30am / Zacks.com - Paid Partner Content | Better Dividend Stock: AbbVie or Viatris? Nov 26 / MotleyFool.com - Paid Partner Content |
| Want $3,000 in Dividend Income Next Year? Invest $50,000 in These 2 Stocks 5:10am / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 10.92 |
| Today’s open | 10.93 |
| Day’s range | 10.85 - 10.96 |
| Volume | 171,898 |
| Average volume (3 months) | 10,360,208 |
| Market cap | $13.5B |
Data as of 4:00pm ET, 12/07/2022
Growth & Valuation
| Earnings growth (last year) | +5.78% |
| Earnings growth (this year) | -8.46% |
| Earnings growth (next 5 years) | +0.43% |
| Revenue growth (last year) | +49.53% |
| P/E ratio | 16.5 |
| Price/Sales | 0.92 |
| Price/Book | 0.66 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| UTHRUnited Therapeutics ... | +0.41 | +0.15% |
| ---- | ||
| ---- | ||
| ---- |
Data as of 3:59pm ET, 12/07/2022
Financials
| Next reporting date | February 27, 2023 |
| EPS forecast (this quarter) | $0.72 |
| Annual revenue (last year) | $17.9B |
| Annual profit (last year) | -$1.3B |
| Net profit margin | -7.11% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Canonsburg, Pennsylvania |
Forecasts
